HHT120
/ Zhejiang Huahai Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 01, 2023
Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Characteristics of HHT120 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=0 | Withdrawn | Sponsor: Shanghai Synergy Pharmaceutical Sciences Co., Ltd. | N=92 ➔ 0 | Not yet recruiting ➔ Withdrawn
Enrollment change • Trial withdrawal
June 10, 2022
Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Characteristics of HHT120 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=92 | Not yet recruiting | Sponsor: Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
New P1 trial
1 to 2
Of
2
Go to page
1